InvestorsHub Logo
Followers 253
Posts 17999
Boards Moderated 0
Alias Born 01/19/2006

Re: lizzy241 post# 298772

Sunday, 09/13/2020 8:58:51 PM

Sunday, September 13, 2020 8:58:51 PM

Post# of 426689
Today’s PR from GILD confirms the WSJ news yesterday, see post # 298668. GILD may find Vascepa’s anti-inflammatory properties useful in combatting cytokines released by mabs in treating a host of solid tumors. Trodelvy has been approved by FDA, was launched in May 2020, and joins Yescarta and Tecartus as “Foundational to Gilead’s Oncolgy Franchise.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News